Today, February 28, we mark Rare Disease Day, a day dedicated to raising awareness about rare diseases and highlighting the need for continued research and collaboration. At FRAXA Research Foundation, we are committed to advancing research on Fragile X syndrome, one of the most common rare diseases that affects many individuals and families worldwide.
Collaboration is critical to accelerate progress towards effective treatments and ultimately a cure for Fragile X syndrome. We have partnered with several non-profit, academic, and industry organizations to achieve this goal. Our partnerships with companies like WuXi AppTec, GEXVal, Shionogi, Tetra, Ulysses Neuroscience, and Purposeful have been crucial in advancing research on Fragile X.
FRAXA’s mission is to find effective treatments and ultimately a cure for Fragile X syndrome. We directly fund research grants and fellowships at top universities around the world. We partner with biomedical and pharmaceutical companies, large and small, to bridge the gap between research discoveries and actual treatments.
Treatments for Fragile X are likely to help people affected by autism, Alzheimer’s, and other brain disorders.
To learn more about FRAXA's Fragile X syndrome research, to get involved with Fragile X awareness and events or to donate to FRAXA research, visit www.fraxa.org
Let's Connect
Facebook: [ Ссылка ]
Instagram: [ Ссылка ]
LinkedIn: [ Ссылка ]
Twitter: [ Ссылка ]
Website: [ Ссылка ]
